BREA, Calif., Aug. 24, 2020 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay. The new IgM antibody test ...
Announcing a new article publication for Zoonoses journal. The COVID-19 pandemic, which was caused by SARS-CoV-2, has had a significant effect on global public health, economies, and societies ...
Singapore, Dec 9, 2021 - (ACN Newswire) - - Biolidics Limited ("Biolidics" or the "Company" and together with its subsidiaries, the "Group"), a medical technology company with a focus on innovative ...
Beckman Coulter has announced that its Access SARS-CoV-2 IgG assay is now available in markets accepting the CE Mark. The company has already shipped tests to more than 400 hospitals, clinics and ...
MARCY L’ÉTOILE, France--(BUSINESS WIRE)--Regulatory News: bioMérieux (Paris:BIM), a world leader in the field of in vitro diagnostics, today announced the CE marking of VIDAS ® anti-SARS-CoV-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results